Latest News

Date Title Topic
17 Jun 2016 Registration Open for ESMO Asia 2016
16 Jun 2016 Adjuvant Combination Therapy Improves Survival in Pancreatic Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
14 Jun 2016 NICE UK Issues New Guidance for Cabazitaxel Genitourinary cancers - Anticancer agents & Biologic therapy
13 Jun 2016 ESMO 2016 Media Alert: From Disease Treatment to Patient Care
13 Jun 2016 EMA Recommends Granting a Marketing Authorisation for Generic Bortezomib Haematologic malignancies - Anticancer agents & Biologic therapy
08 Jun 2016 Immune Modulation in Colorectal and Anal Cancers Gastrointestinal cancers - Cancer Immunology and Immunotherapy
07 Jun 2016 EMA Recommends Extension of Therapeutic Indications for Brentuximab Vedotin Haematologic malignancies - Anticancer agents & Biologic therapy
07 Jun 2016 ESMO Workshop: Cancer Patient Advocacy Networks Driving Research
06 Jun 2016 FDA Approves New Diagnostic Imaging Agent to Detect Rare Neuroendocrine Tumours Imaging - Endocrine cancers
03 Jun 2016 FDA Approves First Blood Test to Detect EGFR mutations associated with NSCLC Personalised medicine - Lung and other thoracic tumours
03 Jun 2016 ESMO is Hiring!
02 Jun 2016 Everolimus for the Treatment of Advanced, Non-Functional Neuroendocrine Tumours of the Lung or Gastrointestinal Tract (RADIANT-4): a Randomised, Placebo-Controlled, Phase 3 Study Endocrine cancers
02 Jun 2016 FDA Approves New Diagnostic Imaging Agent to Detect Recurrent Prostate Cancer Genitourinary cancers - Imaging
01 Jun 2016 All European Scientific Articles to be Freely Accessible by 2020 Bioethics, legal and economic issues
31 May 2016 EMA Recommends to Refuse Marketing Authorisation for Ixazomib Haematologic malignancies - Anticancer agents & Biologic therapy